Adverum Biotechnologies Inc (NASDAQ:ADVM)
| 1.19 Delayed Data As of 3:59pm ET |  +0.05 / +4.39%Today’s Change | 0.53 Today|||52-Week Range 1.82 | +105.35% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 2.3M | 1.5M | 1.8M | 1.6M | |
| Depreciation And Amortization | 812.0K | 1.6M | 2.1M | 1.8M | ||
| Operating Expenses | Gross Income | -- | -- | -- | -- | -- |
| General Expenses | 46.9M | 52.2M | 58.1M | 72.9M | ||
| Research And Development | 25.6M | 32.0M | 40.3M | 50.1M | ||
| Total Operating Expenses | 47.7M | 53.9M | 60.2M | 74.7M | ||
| Non-Operating Expenses | Operating Income | -45.4M | -52.4M | -58.4M | -73.1M | |
| Extraordinary Charge | -2.6M | -63.2M | -1.0M | -5.2M | ||
| Other Expenses | 370.0K | 762.0K | 2.7M | 4.4M | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -47.6M | -114.8M | -56.7M | -73.9M | |
| Income Taxes | -100.0K | -1.1M | -507.0K | -1.3M | ||
| Net Income | -47.5M | -113.7M | -56.1M | -72.6M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 25.5M | 36.2M | 43.7M | 61.4M | |
| Shares To Calculate EPS Diluted | 25.5M | 36.2M | 43.7M | 61.4M | ||
| Earnings Per Share | EPS | -$1.86 | -$3.14 | -$1.29 | -$1.18 | |
| EPS Diluted | -$1.86 | -$3.14 | -$1.29 | -$1.18 | ||
